+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Bladder Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Bladder Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Bone Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Bone Neoplasms - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cervical Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Cervical Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Colorectal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Colorectal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 550 Pages
  • Global
From
Cutaneous T-Cell Lymphoma (CTCL) - Pipeline Insight, 2024 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma (CTCL) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HR Positive/ HER2 Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Diffuse Intrinsic Pontine Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Diffuse Intrinsic Pontine Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Endometrial Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Endometrial Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Esophageal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Fallopian tube cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Fallopian tube cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Gastric Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 550 Pages
  • Global
From
From
Glioblastoma multiforme (GBM) - Pipeline Insight, 2024 - Product Thumbnail Image

Glioblastoma multiforme (GBM) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 450 Pages
  • Global
From
Indolent Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Indolent Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Myelodysplastic Syndrome with Excess Blasts2 - Pipeline Insight, 2024 - Product Thumbnail Image

Myelodysplastic Syndrome with Excess Blasts2 - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Non-Hodgkin Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Non-Hodgkin Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 450 Pages
  • Global
From
Oropharyngeal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Oropharyngeal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Pancreatic Adenocarcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Pancreatic Adenocarcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Pancreatic Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 260 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more